Intravenous glutathione may offer a positive contribution in the treatment of Parkinson's. It was Dr. Perlmutter, a neurologist from the United States, who discovered the link between free radical damage in the brain and Parkinson's disease. To treat Parkinson's, he addresses free radical damage by using intravenous glutathione.
See below a video about this treatment and the remarkable results it achieves. The treatment involves administering glutathione intravenously (directly into the bloodstream).
The primary cause of Parkinson's and research with intravenous glutathione
Glutathione is an antioxidant produced by the body itself. This substance is vital for brain health and healthy liver function. Patients diagnosed with Parkinson's disease are severely deficient in glutathione. This fact is overlooked by conventional and common approaches to this disease. The usual treatment focuses almost exclusively on boosting the available amount of dopamine.
In a study conducted in Italy, Parkinson's patients were administered glutathione intravenously twice daily for 30 days. Participants were examined at intervals ranging from one month to six months. The symptoms of all patients were significantly improved after therapy with glutathione. There was even a 42 percent decrease in disability. Once therapy with glutathione stopped, so did the effects. The researchers reported virtually no side effects following the treatment.
Intravenous glutathione treatment in Parkinson's disease
In 1998, Dr. Perlmutter began administering intravenous glutathione to his patients at Perlmutter Health Center (U.S.A.). After the initial administration, patients often experienced an improvement in symptoms after only 15 minutes. Parkinson's patients treated with glutathione almost always experience great improvement with regard to stiffness, mobility, speech, mood and tremor (shaking). Dr. Perlmutter has seen patients who were forcibly confined to a wheelchair walk again after just a few treatments with intravenous glutathione.
Optimal absorption of glutathione
Glutathione is the most powerful antioxidant in the brain and provides protection of the brain from free radical damage. It can slow the progression of the disease. In addition to the fact that intravenous glutathione protects the brain from free radical damage, glutathione also makes cells more sensitive to the neurotransmitter dopamine. Dr. Perlmutter's studies show that glutathione therapy works very well in combination with L-dopa, allowing patients to require lower doses of the drug.
Yet another benefit of this therapy, is that glutathione improves the detoxifying ability of the liver. This protects the brain from toxins associated with Parkinson's disease. Glutathione cannot be taken orally because it is broken down in the stomach before it can reach the bloodstream. For this reason, it may be valuable to use supplements, such as NAC and alpha-lipoic acid, which bypass the stomach and through a natural route increase glutathione levels a little bit.
A true glutathione boost is achieved only when administered directly into the bloodstream. Intravenous glutathione therapy is to date the best option for significantly increasing glutathione levels. The body needs a constant source of glutathione to function normally. Because Parkinson's patients do not produce enough glutathione, they should receive treatments for this. Normally, intravenous glutathione therapy is given one to three times a week. Each treatment lasts about 20 minutes.
Meanwhile, our clinic has also accumulated many patient experiences with other supportive treatments.